ArticleScientific reports2026
Progesterone receptor, prokineticin 1, LncRNA-H19, and miR-210 in molecular regulation of recurrent implantation failure.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Recurrent implantation failure (RIF) is a major challenge in reproductive medicine. This study explores the expression profiles and interactions of progesterone receptor B (PGR-B), prokineticin 1 (PROK1), prokineticin receptor 1 (PROKR1), and their regulatory associations with microRNA-210-5p (miR-210-5p) and long non-coding RNA H19 (lncRNA-H19) within endometrial tissue. This case-control study was conducted from June 2021 to July 2023, involving 50 patients with recurrent implantation failure (RIF) and a control group of 50 women with successful term pregnancies. Participants were recruited from Arash Hospital in Tehran, Iran. Hysteroscopic assessments were done for the RIF group, while the control group had sampling via Pipelle catheter. We measured the expression levels of key molecular markers, including PGR-B, PROK1, PROKR1, lncRNA-H19, and miR-210-5p, using quantitative real-time PCR (qRT-PCR). Our findings demonstrate significantly low expression and protein levels of PGR-B and PROK1, suggesting a potential dysregulation of these biomolecules in the studied context. Notably, we observed a strong positive correlation between PGR-B and PROKR1, suggesting a synergistic regulatory relationship, potentially influencing endometrial signaling pathways. Conversely, in fertile women, PGR-B and PROK1 exhibited a positive correlation with miR-210-5p, implicating miR-210-5p as a potential activator of PGR-B downstream pathways. Additionally, a positive correlation between PGR-B and PROK1 with lncRNA-H19 was identified, hinting at a complex regulatory network involving these non-coding RNAs. Our findings indicated that a regulatory network involving PGR‑B, PROK1, PROKR1, lncRNA‑H19, and miR‑210‑5p in women with RIF. The significant correlation between these molecules underscores the importance of angiogenesis, a novel mechanistic link to impaired decidualization and endometrial receptivity. It provides new insight into the molecular basis of implantation failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.